| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Euripedes Constantino Miguel | Q18476478 |
| Dan J. Stein | Q5213742 | ||
| Odile A van den Heuvel | Q72932510 | ||
| P2093 | author name string | H Blair Simpson | |
| Christine Lochner | |||
| Y C Janardhan Reddy | |||
| Daniel L C Costa | |||
| Roseli G Shavitt | |||
| P2860 | cites work | DSM-5 | Q3064664 |
| Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: a practical clinical trial | Q84929683 | ||
| Disorder-specific genetic factors in obsessive-compulsive disorder: A comprehensive meta-analysis | Q86826203 | ||
| A Pilot Test of the Additive Benefits of Physical Exercise to CBT for OCD | Q86865391 | ||
| Emotional Processing in Obsessive-Compulsive Disorder: A Systematic Review and Meta-analysis of 25 Functional Neuroimaging Studies | Q88088581 | ||
| Evolution of gamma knife capsulotomy for intractable obsessive-compulsive disorder | Q88618983 | ||
| Combination Therapy of Serotonin Reuptake Inhibitors and Memantine for Obsessive- Compulsive Disorder: A Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials | Q88978928 | ||
| Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A network meta-analysis | Q90702046 | ||
| The association between anxiety, traumatic stress, and obsessive-compulsive disorders and chronic inflammation: A systematic review and meta-analysis | Q91356169 | ||
| Obsessive-Compulsive Disorder: Puzzles and Prospects | Q92849575 | ||
| Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder | Q22255556 | ||
| Identification of a common neurobiological substrate for mental illness | Q23890289 | ||
| Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review | Q24602117 | ||
| The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication | Q24654685 | ||
| A Framework for Understanding the Emerging Role of Corticolimbic-Ventral Striatal Networks in OCD-Associated Repetitive Behaviors | Q26770749 | ||
| Response inhibition and interference control in obsessive-compulsive spectrum disorders | Q26863507 | ||
| A Critical Review of Magnetic Resonance Spectroscopy Studies of Obsessive-Compulsive Disorder | Q27025872 | ||
| Evidence-Based Assessment of Obsessive-Compulsive Disorder | Q28077756 | ||
| Bilateral thermal capsulotomy with MR-guided focused ultrasound for patients with treatment-refractory obsessive-compulsive disorder: a proof-of-concept study | Q28252080 | ||
| DST Studies in Psychotic Depression: A Meta-Analysis | Q28253516 | ||
| The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability | Q28272890 | ||
| Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V | Q28275558 | ||
| Encephalitis lethargica: lessons for contemporary neuropsychiatry | Q30417479 | ||
| Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD | Q30498546 | ||
| Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors | Q30561087 | ||
| Musical obsessions: a comprehensive review of neglected clinical phenomena | Q30562181 | ||
| Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study | Q30671293 | ||
| Who qualifies for deep brain stimulation for OCD? Data from a naturalistic clinical sample | Q30754526 | ||
| Shared white matter alterations across emotional disorders: A voxel-based meta-analysis of fractional anisotropy | Q30831662 | ||
| Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). | Q30836997 | ||
| Neuroimaging of psychotherapy for obsessive-compulsive disorder: A systematic review | Q30984126 | ||
| ENIGMA and the individual: Predicting factors that affect the brain in 35 countries worldwide | Q31031716 | ||
| Sensory phenomena in obsessive-compulsive disorder and tic disorders: a review of the literature. | Q33336996 | ||
| There is an app for that! The current state of mobile applications (apps) for DSM-5 obsessive-compulsive disorder, posttraumatic stress disorder, anxiety and mood disorders. | Q33454789 | ||
| Tracking the mechanisms of deep brain stimulation for neuropsychiatric disorders | Q33809727 | ||
| Complementary medicine, self-help, and lifestyle interventions for obsessive compulsive disorder (OCD) and the OCD spectrum: a systematic review | Q33914679 | ||
| Transcranial direct current stimulation in obsessive-compulsive disorder: emerging clinical evidence and considerations for optimal montage of electrodes. | Q38486000 | ||
| Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014. | Q38539038 | ||
| Global mental health and neuroscience: potential synergies | Q38584734 | ||
| Remote cognitive-behavior therapy for obsessive-compulsive symptoms: A meta-analysis. | Q38614420 | ||
| The classification of Obsessive-Compulsive and Related Disorders in the ICD-11. | Q38641529 | ||
| Obsessive-compulsive disorder in the elderly: A report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). | Q38669829 | ||
| Brain circuitry of compulsivity | Q38681737 | ||
| The role of habit in compulsivity | Q38698930 | ||
| An updated meta-analysis: Short-term therapeutic effects of repeated transcranial magnetic stimulation in treating obsessive-compulsive disorder | Q38740147 | ||
| Systematic review of environmental risk factors for Obsessive-Compulsive Disorder: A proposed roadmap from association to causation | Q38788121 | ||
| Inhibitory learning approaches to exposure therapy: A critical review and translation to obsessive-compulsive disorder | Q38806455 | ||
| Cognitive Dysfunction in Obsessive-Compulsive Disorder. | Q38841197 | ||
| Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment | Q38849752 | ||
| Adult obsessive-compulsive disorder and quality of life outcomes: A systematic review and meta-analysis | Q38926648 | ||
| Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis | Q38955290 | ||
| Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder. | Q38963333 | ||
| The effect of trauma on the severity of obsessive-compulsive spectrum symptoms: A meta-analysis | Q39153262 | ||
| Mindfulness-based cognitive therapy as an augmentation treatment for obsessive-compulsive disorder. | Q39159783 | ||
| Distinct Subcortical Volume Alterations in Pediatric and Adult OCD: A Worldwide Meta- and Mega-Analysis | Q39409083 | ||
| Meta-analysis of association between obsessive-compulsive disorder and the 3' region of neuronal glutamate transporter gene SLC1A1. | Q39431998 | ||
| Patient adherence and treatment outcome with exposure and response prevention for OCD: Which components of adherence matter and who becomes well? | Q39516686 | ||
| Obsessive-compulsive disorder: is there a frontal lobe dysfunction? | Q39524573 | ||
| Molecular genetics of obsessive–compulsive disorder: a comprehensive meta-analysis of genetic association studies | Q39607970 | ||
| Multimodal voxel-based meta-analysis of white matter abnormalities in obsessive-compulsive disorder | Q39668866 | ||
| Structural and Functional Brain Abnormalities in Attention-Deficit/Hyperactivity Disorder and Obsessive-Compulsive Disorder: A Comparative Meta-analysis | Q39700736 | ||
| Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis | Q39718924 | ||
| Cortical thickness in obsessive-compulsive disorder: multisite mega-analysis of 780 brain scans from six centres | Q39751957 | ||
| Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. | Q40042663 | ||
| Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part I-Psychiatric and Behavioral Interventions | Q40128672 | ||
| High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea | Q40778063 | ||
| Open-Label trial on the effects of memantine in adults with obsessive-compulsive disorder after a single ketamine infusion | Q41262628 | ||
| Family accommodation in adult obsessive-compulsive disorder: clinical perspectives | Q42364440 | ||
| Validation of the University of São Paulo Sensory Phenomena Scale: initial psychometric properties | Q42630196 | ||
| The structure of genetic and environmental risk factors for dimensional representations of DSM-5 obsessive-compulsive spectrum disorders | Q42634897 | ||
| Dopamine D(1) receptor binding in the anterior cingulate cortex of patients with obsessive-compulsive disorder. | Q43031637 | ||
| Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder | Q43281037 | ||
| Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder | Q43292779 | ||
| Symptom dimensions, clinical course and comorbidity in men and women with obsessive-compulsive disorder | Q43434164 | ||
| Clinical predictors of drug response in obsessive-compulsive disorder. | Q43761139 | ||
| The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study | Q33915297 | ||
| Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder | Q33926476 | ||
| Maximizing exposure therapy: an inhibitory learning approach | Q33968137 | ||
| A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder | Q33994634 | ||
| N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial | Q34034265 | ||
| The cognitive-affective neuroscience of obsessive-compulsive disorder | Q34108477 | ||
| Scrupulosity: a unique subtype of obsessive-compulsive disorder | Q34120611 | ||
| Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders | Q34124435 | ||
| Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). | Q34141417 | ||
| The systematic desensitization treatment of neuroses | Q34249671 | ||
| Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care | Q34271431 | ||
| Gender in obsessive-compulsive disorder: clinical and genetic findings. | Q34304700 | ||
| Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview | Q34310654 | ||
| Repetitive transcranial magnetic stimulation (rTMS) for obsessive–compulsive disorder (OCD): An exploratory meta-analysis of randomized and sham-controlled trials | Q34341099 | ||
| Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators | Q34404992 | ||
| Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference | Q34444042 | ||
| Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study | Q34445382 | ||
| The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions | Q34487447 | ||
| High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial. | Q34564349 | ||
| Florida Obsessive-Compulsive Inventory: development, reliability, and validity | Q34659240 | ||
| A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION. | Q34671104 | ||
| "WHAT'S BUGGING THE GUT IN OCD?" A REVIEW OF THE GUT MICROBIOME IN OBSESSIVE-COMPULSIVE DISORDER. | Q34674629 | ||
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision | Q34865036 | ||
| Obsessive compulsive personality disorder as a predictor of exposure and ritual prevention outcome for obsessive compulsive disorder | Q35072065 | ||
| Culture and the anxiety disorders: recommendations for DSM-V. | Q35110512 | ||
| Trauma-related obsessive-compulsive disorder: a review | Q35136395 | ||
| Open-label study of duloxetine for the treatment of obsessive-compulsive disorder | Q35203670 | ||
| Treatment of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review | Q35204911 | ||
| WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. | Q35651392 | ||
| Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Meta-Analysis of Treatment Outcome and Predictors of Response | Q35712120 | ||
| Role and clinical implications of atypical antipsychotics in anxiety disorders, obsessive-compulsive disorder, trauma-related, and somatic symptom disorders: a systematized review | Q35955966 | ||
| Glutamatergic agents for OCD and related disorders | Q35967025 | ||
| A multidimensional model of obsessive-compulsive disorder | Q36022775 | ||
| Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials | Q36077216 | ||
| Quality of life, family burden and associated factors in relatives with obsessive–compulsive disorder | Q44283919 | ||
| Perceived burden and quality of life of caregivers in obsessive–compulsive disorder | Q44425369 | ||
| A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder. | Q44742683 | ||
| High-dose duloxetine for treatment-resistant obsessive-compulsive disorder: a case report with sustained full remission. | Q45988900 | ||
| High-dose selective serotonin reuptake inhibitors in OCD: a systematic retrospective case notes survey | Q46058167 | ||
| Neuroimaging genomics in psychiatry-a translational approach | Q46300803 | ||
| A pilot randomized controlled trial of aerobic exercise as an adjunct to OCD treatment | Q46307047 | ||
| Randomized controlled trial of yogic meditation techniques for patients with obsessive-compulsive disorder | Q46468848 | ||
| Generic and illness-specific quality of life in obsessive-compulsive disorder | Q46668862 | ||
| Long-term outcome of obsessive-compulsive disorder in adults: a meta-analysis | Q46778445 | ||
| Neural dysfunction during temporal discounting in paediatric Attention-Deficit/Hyperactivity Disorder and Obsessive-Compulsive Disorder | Q47095233 | ||
| Cortical Abnormalities Associated With Pediatric and Adult Obsessive-Compulsive Disorder: Findings From the ENIGMA Obsessive-Compulsive Disorder Working Group | Q47551111 | ||
| Shared and Disorder-Specific Neurocomputational Mechanisms of Decision-Making in Autism Spectrum Disorder and Obsessive-Compulsive Disorder. | Q47594351 | ||
| Geographic inequity in the availability of cognitive behavioural therapy in England and Wales: a 10-year update | Q47741637 | ||
| Trans-diagnostic comparison of response inhibition in Tourette's disorder and obsessive-compulsive disorder | Q47768273 | ||
| A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults. | Q47769190 | ||
| Neural correlates of affective and non-affective cognition in obsessive compulsive disorder: A meta-analysis of functional imaging studies | Q47834842 | ||
| A call for prevention and early intervention in obsessive-compulsive disorder | Q47916766 | ||
| Mapping Compulsivity in the DSM-5 Obsessive Compulsive and Related Disorders: Cognitive Domains, Neural Circuitry, and Treatment | Q48016660 | ||
| The medial forebrain bundle as a target for deep brain stimulation for obsessive-compulsive disorder | Q48053075 | ||
| Adding motivational interviewing and thought mapping to cognitive-behavioral group therapy: results from a randomized clinical trial | Q48221197 | ||
| Electroacupuncture for refractory obsessive-compulsive disorder: a pilot waitlist-controlled trial | Q48413410 | ||
| Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder | Q48431922 | ||
| Quality of life in patients with obsessive compulsive disorder: A longitudinal study from India | Q48598351 | ||
| The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems | Q48863871 | ||
| Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder | Q48876360 | ||
| A Meta-Analysis of the Effectiveness of Different Cortical Targets Used in Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Obsessive-Compulsive Disorder (OCD). | Q50103943 | ||
| Metabolic and Cardiovascular Complications in Obsessive-Compulsive Disorder: A Total Population, Sibling Comparison Study With Long-Term Follow-up | Q50209933 | ||
| Executive functions in obsessive-compulsive disorder: An activation likelihood estimate meta-analysis of fMRI studies | Q50551342 | ||
| Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study | Q50561917 | ||
| N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study | Q50566963 | ||
| A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder | Q50782433 | ||
| Risk of obsessive-compulsive disorder in pregnant and postpartum women: a meta-analysis | Q51245038 | ||
| Obsessional ruminations | Q51324355 | ||
| The Brown Assessment of Beliefs Scale: Reliability and Validity | Q51997127 | ||
| The epidemiology of obsessive-compulsive disorder in five US communities | Q52068187 | ||
| N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial | Q53162022 | ||
| Obsessional-compulsive problems: a cognitive-behavioural analysis | Q53772537 | ||
| Escitalopram in obsessive–compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study | Q56909849 | ||
| Successfully treating 90 patients with obsessive compulsive disorder in eight days: the Bergen 4-day treatment | Q57024838 | ||
| Neuroscientifically Informed Formulation and Treatment Planning for Patients With Obsessive-Compulsive Disorder: A Review | Q57142990 | ||
| D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis | Q57700334 | ||
| Mapping Structural Brain Alterations in Obsessive-Compulsive Disorder | Q58957841 | ||
| Cognitive assessment of obsessive-compulsive disorder | Q60456915 | ||
| Obsessive-compulsive disorder and global mental health | Q61809157 | ||
| Early intervention for obsessive compulsive disorder: An expert consensus statement | Q63684018 | ||
| The treatment of chronic obsessive-compulsive neurosis | Q70535664 | ||
| Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder | Q71496136 | ||
| Interactions of serotonin reuptake inhibitors with tricyclic antidepressants | Q72088115 | ||
| A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder | Q84446951 | ||
| Cognitive behavioral therapy for obsessive-compulsive disorder: an update | Q36228214 | ||
| The descriptive epidemiology of obsessive-compulsive disorder. | Q36367999 | ||
| Structural covariance of neostriatal and limbic regions in patients with obsessive-compulsive disorder | Q36609793 | ||
| Neurobiology of rodent self-grooming and its value for translational neuroscience | Q36825003 | ||
| The analytical epidemiology of obsessive-compulsive disorder: risk factors and correlates | Q36906381 | ||
| Precision psychiatry: a neural circuit taxonomy for depression and anxiety | Q37042718 | ||
| Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. | Q37140673 | ||
| Mortality Among Persons With Obsessive-Compulsive Disorder in Denmark. | Q37371924 | ||
| Neuroimaging in obsessive-compulsive disorder | Q37390726 | ||
| Efficacy of mindfulness-integrated cognitive behavior therapy in patients with predominant obsessions | Q37609719 | ||
| Challenges using motivational interviewing as an adjunct to exposure therapy for obsessive-compulsive disorder | Q37630137 | ||
| Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial | Q37639264 | ||
| Treatment response, symptom remission, and wellness in obsessive-compulsive disorder | Q37649278 | ||
| Meta-analysis of the symptom structure of obsessive-compulsive disorder | Q37678101 | ||
| Quality of life in children and adolescents with obsessive-compulsive disorder: a systematic review and meta-analysis | Q37682864 | ||
| Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition | Q37686937 | ||
| Addressing reverse inference in psychiatric neuroimaging: Meta-analyses of task-related brain activation in common mental disorders | Q37696565 | ||
| Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? | Q37700925 | ||
| Internet-Delivered Health Interventions That Work: Systematic Review of Meta-Analyses and Evaluation of Website Availability | Q37742296 | ||
| Etiology of obsessions and compulsions: A meta-analysis and narrative review of twin studies | Q37949119 | ||
| Quality of life in obsessive compulsive disorder | Q38070934 | ||
| Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment | Q38098475 | ||
| Obsessive compulsive disorder and the glutamatergic system | Q38165707 | ||
| The global burden of anxiety disorders in 2010. | Q38180929 | ||
| Deep brain stimulation for obsessive-compulsive disorder: systematic review and evidence-based guideline sponsored by the American Society for Stereotactic and Functional Neurosurgery and the Congress of Neurological Surgeons (CNS) and endorsed by t | Q38232610 | ||
| Striatal circuits, habits, and implications for obsessive-compulsive disorder. | Q38252883 | ||
| Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults | Q38355180 | ||
| Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse | Q38373331 | ||
| Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder. | Q38375537 | ||
| Meta-analytic investigations of structural grey matter, executive domain-related functional activations, and white matter diffusivity in obsessive compulsive disorder: an integrative review. | Q38376080 | ||
| A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder | Q38381942 | ||
| RETRACTED: Gamma ventral capsulotomy for obsessive-compulsive disorder: a randomized clinical trial. | Q38426426 | ||
| Can early improvement be an indicator of treatment response in obsessive-compulsive disorder? Implications for early-treatment decision-making | Q38446236 | ||
| P433 | issue | 1 | |
| P921 | main subject | obsessive-compulsive disorder | Q178190 |
| P304 | page(s) | 52 | |
| P577 | publication date | 2019-08-01 | |
| P1433 | published in | Nature Reviews Disease Primers | Q24908540 |
| P1476 | title | Obsessive-compulsive disorder | |
| P478 | volume | 5 |
| Q90183750 | An overview of the first 5 years of the ENIGMA obsessive-compulsive disorder working group: The power of worldwide collaboration |
| Q101237517 | Applications of focused ultrasound in the brain: from thermoablation to drug delivery |
| Q94525677 | Investigating the Role of Glutamate in Obsessive-Compulsive Disorder: Current Perspectives |
| Q99202266 | Psychological, addictive, and health behavior implications of the COVID-19 pandemic |
| Q94561565 | The impact of COVID-19 in the diagnosis and treatment of obsessive-compulsive disorder |
| Q104795216 | Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder |
| Q89720561 | Toward identifying reproducible brain signatures of obsessive-compulsive profiles: rationale and methods for a new global initiative |
Search more.